Topics

Generics transition brings economic benefits to Canada

04:53 EST 8 Nov 2019 | Generics and Biosimilars Initiative

Economic analysis of genericization of cancer medicines in Canada has confirmed their cost-effectiveness. This rare example of an economic evaluation of the benefits of generics was published in Current Oncology [1].

Original Article: Generics transition brings economic benefits to Canada

NEXT ARTICLE

More From BioPortfolio on "Generics transition brings economic benefits to Canada"

Quick Search

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...